Prolonged urinary leakage in the postoperative period of renal hydatic cyst treatment with oral desmopressin: a case report
- First Online:
- Cite this article as:
- Ceylan, C., Baytok, Ö., Doğan, S. et al. J Med Case Reports (2012) 6: 339. doi:10.1186/1752-1947-6-339
Prolonged extravasation after renal and ureter surgeries is a bothersome situation for both the patient and the doctor. It is usually related to the suture line not being watertight. The contact between urine and the edges of the wound also delay healing of the wound. In this situation, the first thing to do is to break the contact between the wound and the urine by inserting an adequate stent. Sometimes, this process is not enough. We approached this problem with a different treatment method for a case involving prolonged drainage.
A 52-year-old Caucasian woman who presented at our clinic with right flank pain was operated on due to a renal hydatic cyst, and cyst removal was performed. On follow-up, prolonged urinary leakage was observed and a desmopressin treatment was started on the patient. Drainage was greatly reduced after desmopressin was started and there was no drainage on the fifth day.
Prolonged extravasation is a bothersome situation and there can be many reasons for this. Whenever traditional approaches are not enough, oral desmopressin therapy can be started reliably if there are no contraindications for the patient. Eventually, contact between urine and the suture site will cease and therefore the fever and healing time will be shortened.
KeywordsDesmopressin treatment Hydatic cyst Renal leakage
Urine leakage and urinoma occur as a result of the disruption of the urinary collecting system at any level from the calyx to the urethra. Persistent urine leakage is frequently seen following iatrogenic injuries such as open and/or laparoscopic renal surgery and percutaneous nephrolithotripsy[1–3]. Dealing with urine leakage generally involves some applications, such as catheter drainage, ureteral stenting and percutaneous nephrostomy placement with open repair versus nephrectomy which is reserved for persistent leakage. However, to the best of our knowledge, the effectiveness of medical therapy in urinary leakage has not been mentioned previously. We claimed that reduction in urinary output can accelerate improvement of urinary leakage. In an effort to test this hypothesis, we used desmopressin, which has antidiuretic effects and can decrease urinary output. Thus, we report our initial experience regarding the effect of desmopressin in reduction of urinary leakage duration following urological surgeries.
Desmopressin is a drug which has been used as a synthetic arginine vasopressin analog for 40 years. This drug has been proved to be effective for the treatment of nocturnal enuresis, central diabetes insipidus and some coagulopathies. The antidiuresis induced by desmopressin is more potent than that of arginine vasopressin, resulting in an increased urine osmolality and decreased urine output. Several investigators have demonstrated significant decreases in nocturnal diuresis and subsequent improvements in sleep[4–7]. In the study of Razzaghi et al. nasal desmopressin (Minirin®) was applied to 7 out of 15 patients and 8 of them were observed without taking any treatment. Urinary leakage duration reduced significantly in the group who had desmopressin (Minirin®) treatment. They observed a dramatic decrease in urine leakage in the group to whom Minirin® was given. They found this result to be statistically significant. Furthermore, Çimentepe et al. reported on a patient whose prolonged urinary leakage following percutaneous nephrolithotomy, which had not stopped although a double pig-tail stent had been inserted, suddenly came to an end with peroral desmopressin treatment. They showed that treatment with oral desmopressin could reduce urinary leakage. In our case, the urinary leakage continued although we inserted a double j stent, but it reduced dramatically during the week following the commencement of oral desmopressin treatment and no complication was observed in the patient. Our study showed that desmopressin can reduce the duration of urinary leakage in these patients.
The use of desmopressin may improve the beneficial effect of other procedures such as catheter drainage, ureteral stenting, and percutaneous nephrostomy placement for incisional urinary leakage. Thus, we have come to the conclusion that patients with prolonged urinary leakage, who do not respond to surgical urinary drainage after renal surgeries, can benefit from desmopressin. We argue that desmopressin medical treatment can be considered an alternative in clinics with many centers and patients and in prolonged clinical studies.
Desmopressin treatment should be considered a safe alternative treatment in prolonged urinary leakage before it becomes chronic, which is an annoying complication in the postoperative period. Desmopressin can be applied orally and it presented no complication in recent blood tests.
Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.